Pig Antibiotics and Welfare Stewardship

Reducing antibiotic use in pig production requires welfare improvements that address the root causes of disease requiring treatment.

Key Facts

Global pig production consumes approximately 25% of all veterinary antibiotics worldwide
Prophylactic antibiotic use — dosing healthy pigs to prevent disease — drives resistance while masking welfare problems
Denmark reduced pig antibiotic use by 50% between 1999 and 2010 through regulatory action and improved husbandry
Pigs in enriched, lower-density systems require fewer antibiotics than pigs in barren, crowded environments
Zinc oxide, used as an antibiotic alternative, is being phased out in the EU due to environmental concerns
Vaccination programs for common pig pathogens reduce antibiotic dependence when implemented correctly
Welfare improvement and antibiotic stewardship are not competing goals — they are aligned interventions

Welfare Considerations

Pig antibiotic stewardship and welfare improvement are mutually reinforcing strategies. High antibiotic use in pig production is a symptom of welfare failures — overcrowding, poor ventilation, stress, and inadequate enrichment create disease pressure that antibiotics manage rather than prevent. Denmark's experience demonstrates that regulatory reduction in antibiotic use, combined with improved husbandry, can be achieved without production loss. The welfare benefit of reducing prophylactic antibiotic use is twofold: it removes the pharmaceutical safety net that enables poor welfare conditions, creating pressure for genuine improvement, and it protects the future effectiveness of antibiotics for treating disease when it occurs.

What You Can Do

Choose pork certified under antibiotic stewardship schemes
Advocate for bans on prophylactic antibiotic use in pig production globally
Support research into vaccination alternatives to antibiotics for common pig diseases
Reduce pork consumption or shift to certified higher-welfare alternatives as a market signal